Published financial brief
3NVNUE
ETHEMA HEALTH CORP
- As of
- 2024-12-31
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
2 data notes
- Input provenance requires review.
- One or more values are unavailable.
Exact-period record
Fundamentals
5 reported periods
| Metric | FY 20202020-12-31 | FY 20212021-12-31 | FY 20222022-12-31 | FY 20232023-12-31 | FY 20242024-12-31 |
|---|---|---|---|---|---|
| Financial statements | |||||
| RevenueUSD millions | 0.3 | 1.9 | 4.8 | 5.3 | 6 |
| Cost of goods soldUSD millions | 0.4 | 1.6 | 3.8 | 5.4 | 6.9 |
| Selling, general and administrative expenseUSD millions | —missing | —missing | —missing | —missing | —missing |
| Depreciation and amortizationUSD millions | 0.1 | 0.3 | 0.5 | 0.5 | 0.5 |
| Net incomeUSD millions | 3.1 | -1.5 | 0.2 | 1.2 | -2.1 |
| Operating profit (EBIT)USD millions | -0.2 | 0 | 0.5 | -0.5 | -1.3 |
| Income taxesUSD millions | 0 | -0.3 | 0.1 | -0.4 | 0 |
| Short-term debtUSD millions | 4.6 | 9.3 | 9.5 | 5.2 | 7.3 |
| Long-term debtUSD millions | 4.6 | 2.2 | 1.9 | 9.4 | 10 |
| Cash and equivalentsUSD millions | 0.8 | 0 | 0.1 | 0.1 | 0.2 |
| ReceivablesUSD millions | 0 | 0.2 | 0.3 | 0.3 | 0.3 |
| InventoryUSD millions | 0 | 0 | 0 | 0 | 0 |
| PayablesUSD millions | 0.8 | 0.4 | 0.2 | 0.4 | 0.8 |
| Net property, plant and equipmentUSD millions | 2.9 | 4.7 | 4.4 | 9.8 | 10.6 |
| Capital expenditureUSD millions | 0 | 0.1 | 0.3 | 5.3 | 0.1 |
| Operating cash flowUSD millions | -0.1 | -0.1 | 1.6 | -0.5 | -0.5 |
| Prepaid expensesUSD millions | 0 | 0 | 0 | 0 | 0 |
| AccrualsUSD millions | —missing | —missing | —missing | —missing | —missing |
| EBITDAUSD millions | -0 | 0.3 | 1 | -0 | -0.9 |
| Working capitalUSD millions | -12.9 | -13.2 | -12.7 | -7.9 | -9.1 |
| Working capital requirementUSD millions | -0.8 | -0.3 | 0.2 | -0 | -0.5 |
| Total debtUSD millions | 9.2 | 11.5 | 11.4 | 14.6 | 17.2 |
| Free cash flowUSD millions | -0.1 | -0.2 | 1.3 | -5.8 | -0.5 |
| Unlevered free cash flowUSD millions | -0 | -0.4 | 0.2 | -5.1 | -0.5 |
| Returns and ratios | |||||
| ROICratio | -8% | 0% | 6.1% | -5.1% | -12.5% |
| Pre-tax ROICratio | -8% | 0% | 8.5% | -5.1% | -12.5% |
| Effective tax rateratio | 0% | 15.2% | 27.5% | 0% | 0% |
| Revenue growthratio | -5.8% | 473.2% | 148.1% | 10.9% | 12.6% |
| EBIT / Revenueratio | -48.4% | 0.2% | 10.1% | -10.2% | -22.2% |
| Revenue / Invested capitalmultiple | 0.17× | 0.32× | 0.83× | 0.5× | 0.56× |
| Cogs Over Revenuesratio | 112.7% | 83.1% | 78.7% | 100.8% | 114.4% |
| Sga Over Revenuesratio | —missing | —missing | —missing | —missing | —missing |
| Da Over Revenuesratio | 35.7% | 16.7% | 11.2% | 9.3% | 7.8% |
| Nfa Over Revenuesratio | 850.2% | 240.1% | 90.6% | 184% | 176.5% |
| Wcr Over Revenuesratio | -245.1% | -13.5% | 3.4% | -0.7% | -8.4% |
| Debt Over Ebitdamultiple | —missing | 35.07× | 11.11× | —missing | —missing |
| St Debt Over Cashmultiple | 5.87× | 189.47× | 67.69× | 74.83× | 29.71× |
| Interest Over Ebitdamultiple | —missing | 8.52× | 1.18× | —missing | —missing |
| Interest Over Nocf Nicfmultiple | -14.63× | -12.77× | 0.96× | -0.14× | -1.9× |
| Nsf Over Wcrmultiple | -4.58× | -35.25× | 56.65× | -130.62× | -13.98× |
Ask this snapshot
Research assistant
3NVNUE · annualSnapshot bd783e1b
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000